Intensity Therapeutics Inc.
INTS | NASDAQ
$3.90
-$0.12 (-2.99%)
Sep 22, 2026, 11:30 AM ET · Market open
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 7K | 7K | n/a | n/a | n/a | n/a | 6K | 6K | 6K | 44.62K | 139.09K | 139.09K | 139.09K | 100.47K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | -7K | -7K | n/a | n/a | n/a | n/a | -6K | -6K | -6K | -44.62K | -139.09K | -139.09K | -139.09K | -100.47K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -11.48M | -11.1M | -11.97M | -12.04M | -12.87M | -15.24M | -16.59M | -16.73M | -15.66M | -11.81M | -8.32M | -6.52M | -5.8M | -6.51M | -7.63M | -8.49M | -8.86M | -8.89M | -8.01M | -7.26M | -5.12M | -3.16M |
Interest Income | 318K | 258K | 179K | 119K | 108K | 189K | 314K | 461.97K | 561.51K | 463.68K | 324K | 148.66K | 2.11K | 2.15K | 2.48K | 2.19K | 1.85K | 2.51K | 2.61K | 8.24K | 7.6K | 6.72K |
Pretax Income | -11.16M | -10.69M | -11.61M | -11.74M | -12.58M | -15.01M | -16.27M | -16.26M | -15.07M | -13.8M | -10.54M | -8.88M | -8.32M | -6.55M | -7.58M | -8.47M | -8.82M | -8.79M | -7.9M | -7.13M | -5M | -3.11M |
Net Income | -11.16M | -10.69M | -11.61M | -11.74M | -12.58M | -15.01M | -16.27M | -16.26M | -15.07M | -13.8M | -10.54M | -8.88M | -8.32M | -6.55M | -7.58M | -8.47M | -8.82M | -8.79M | -7.9M | -7.13M | -5M | -3.11M |
Selling & General & Admin | 5.4M | 5.31M | 5.19M | 4.79M | 5.02M | 5.37M | 6.08M | 6.4M | 6.12M | 4.94M | 3.39M | 2.43M | 1.89M | 2.11M | 2.42M | 2.81M | 2.84M | 2.56M | 2.16M | 1.44M | 795.68K | 534.63K |
Research & Development | 6.08M | 5.79M | 6.79M | 7.25M | 7.85M | 9.87M | 10.5M | 10.33M | 9.53M | 6.83M | 4.79M | 3.88M | 3.68M | 4.21M | 5.13M | 5.68M | 6.02M | 6.33M | 5.86M | 5.83M | 4.33M | 2.62M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 80.71K | 80.71K | 80.71K | 80.74K | 23 | 23 | 23 | n/a | n/a | n/a | n/a |
Operating Expenses | 11.48M | 11.1M | 11.97M | 12.04M | 12.87M | 15.24M | 16.58M | 16.73M | 15.65M | 11.76M | 8.18M | 6.38M | 5.66M | 6.41M | 7.63M | 8.49M | 8.86M | 8.89M | 8.01M | 7.26M | 5.12M | 3.16M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 221.78K | 305.16K | 342.07K | 357.19K | 150.37K | 81.78K | 44.88K | 29.75K | 14.8K | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | -6K | -6K | -6K | -6K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 11.48M | 11.1M | 11.97M | 12.04M | 12.87M | 15.24M | 16.59M | 16.73M | 15.66M | 11.81M | 8.32M | 6.52M | 5.8M | 6.51M | 7.63M | 8.49M | 8.86M | 8.89M | 8.01M | 7.26M | 5.12M | 3.16M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 356 | 356 | 356 | 356 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 27.07M | 25.34M | 13.56M | 1.72M | 754.72K | 606.92K | 576K | 552.16K | 548.48K | 548.36K | 550.6K | 546.4K | 103.6K | 136.4K | 136.4K | 136.4K | 136.4K | 136.4K | 136.4K | 136.4K | 136.4K | 136.4K |
Shares Outstanding (Diluted) | 27.07M | 25.34M | 13.56M | 1.72M | 754.72K | 606.93K | 576.04K | 552.19K | 548.49K | 548.38K | 550.61K | 546.43K | 140.66K | 136.4K | 136.4K | 136.4K | 136.4K | 136.4K | 136.4K | 136.4K | 136.4K | 136.4K |
EPS (Basic) | -4.83 | -6.97 | -11.51 | -15.80 | -20.50 | -26.25 | -29.25 | -29.50 | -27.50 | -54.25 | -55.50 | -60.75 | -69.50 | -48 | -55.50 | -62 | -64.50 | -64 | -57.50 | -52 | -36.50 | -22.75 |
EPS (Diluted) | -4.83 | -6.97 | -11.51 | -15.80 | -20.50 | -26.25 | -29.25 | -29.50 | -27.50 | -54.25 | -55.50 | -60.75 | -69.50 | -48 | -55.50 | -62 | -64.50 | -64 | -57.50 | -52 | -36.50 | -22.75 |
EBITDA | -8.5M | -7.95M | -8.86M | -9M | -12.57M | -14.99M | -16.25M | -16.23M | -15.05M | -13.53M | -10.09M | -8.35M | -7.74M | -6.16M | -7.32M | -8.29M | -8.7M | -8.67M | -7.82M | -7.02M | -4.9M | -3.06M |
EBIT | -11.24M | -10.69M | -11.61M | -11.74M | -12.58M | -15.01M | -16.27M | -16.26M | -15.07M | -13.58M | -10.23M | -8.54M | -7.97M | -6.4M | -7.5M | -8.43M | -8.79M | -8.77M | -7.92M | -7.17M | -5.05M | -3.16M |
Depreciation & Amortization | 2.74M | 2.74M | 2.75M | 2.74M | 13K | 19K | 19K | 24.89K | 19.91K | 52.53K | 147K | 186.54K | 229.5K | 235.42K | 179.04K | 133.61K | 88.63K | 99.9K | 98.21K | 153.34K | 153.34K | 97.54K |
Add to Watchlist
Select watchlists to add or remove INTS